{"id":"W4362472973","doi":"10.1016/j.msard.2022.104360","title":"MRI and Clinical Outcomes of Evobrutinib, a Bruton's Tyrosine Kinase Inhibitor, in Relapsing Multiple Sclerosis Over 2.5 Years of the Open-Label Extension to a Phase 2 Trial","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Placebo; Multiple sclerosis; Double blind; Magnetic resonance imaging; Internal medicine; Nuclear medicine; Tolerability; Gastroenterology; Adverse effect; Pathology; Immunology; Radiology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001479139,0.0002654585,0.0009089527,0.0003529295,0.0001383766,0.00004159841,0.0002767821,0.0003615995,0.00002447594],"category_scores_gemma":[0.003681182,0.0001983099,0.000191835,0.001439875,0.0005439309,0.0001451326,0.000847224,0.0004757947,0.000007040914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004290936,"about_ca_system_score_gemma":0.0007148393,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003766136,"about_ca_topic_score_gemma":0.0007242692,"domain_scores_codex":[0.9967665,0.0002653679,0.001186757,0.000697175,0.000589124,0.0004950463],"domain_scores_gemma":[0.9974162,0.001264991,0.0002763523,0.0006662681,0.0001049983,0.000271217],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09947557,0.01284562,0.5220689,0.0005443629,0.001041879,0.00006727724,0.005382166,0.00049795,0.1374132,0.00009207935,0.005680982,0.21489],"study_design_scores_gemma":[0.4390409,0.001358016,0.5294228,0.00162762,0.0001483563,0.000003675606,0.00045718,0.0265322,0.0008566288,0.00003985237,0.0002722345,0.0002405226],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950246,0.0007330254,0.000005358643,0.0009681535,0.0004870211,0.002628593,0.00004858636,0.00004427008,0.00006042728],"genre_scores_gemma":[0.9962267,0.002971359,0.0003004294,0.000133977,0.00002736087,0.00005368466,0.0000213267,0.00005813054,0.000207003],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3395653,"threshold_uncertainty_score":0.8086842,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09464708955712986,"score_gpt":0.3631750525634793,"score_spread":0.2685279630063495,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}